Haz-Map: Information on Hazardous Chemicals and Occupational Diseases
Designed for health and safety professionals and consumers seeking information about the adverse effects of workplace exposures to chemical and biological agents.
Designed for health and safety professionals and consumers seeking information about the adverse effects of workplace exposures to chemical and biological agents.
Topics include healthcare administration and other non-clinical healthcare institution management aspects.
Collection of current and historical assessments of health services and technology published by the National Library of Medicine.
Includes evidence-based reviews from the Agency for Healthcare Research and Quality (AHRQ), protocols from the Substance Abuse and Mental Health Services Administration (SAMHSA), recommendations from the U.S. Preventive Services Task Force (USPSTF), consensus reports and clinical practice guidelines, and guidance and research on methods from the AHR.
Note: Some information in this resource is outdated and should only be used for historical reference.
Brings together details on ongoing studies of the medical, social, ethical, and economic implications of healthcare interventions.
A collection of patient-level data from State data organizations, hospital associations, private data organizations, and the Federal government.
Coverage includes health policy issues, including cost and quality of health services, medical practice patterns, access to health care programs, and outcomes of treatments at the national, State, and local market levels.
Contains citations to published literature and research. Focuses on both the clinical and non-clinical aspects of health care delivery (health services, technology, administration).
Topics include evaluation of patient outcomes; effectiveness of procedures, programs, products, services, and processes; administration and planning of health facilities, services, and manpower; health care policy, economics, and financial management.
Please be mindful of copyright and licensing requirements for use.
Provides information on HIV-related drugs, including FDA-approved antiretroviral and opportunistic infection drugs and investigational drugs.